Investigating a new pathway for eye problems caused by diabetes
A Novel Pathogenic Pathway for Diabetic Keratopathy
This study is looking at how a protein called PPARα affects eye health in people with diabetes, and it’s testing a medication called fenofibrate to see if it can help improve nerve function and sensitivity in the cornea, which could lead to better vision for those with diabetic keratopathy.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of North Texas Hlth Sci Ctr NIH-funded |
| Lab location | 1 site (Fort Worth, United States) |
| Project ID | NIH-11006330 on NIH RePORTER |
What this research studies
This research focuses on understanding diabetic keratopathy, a condition that affects the eyes of people with diabetes and can lead to vision loss. The study aims to explore the role of a specific protein, PPARα, which is involved in lipid metabolism and may influence nerve health in the cornea. By examining how PPARα levels change in diabetic patients and testing a medication called fenofibrate, the researchers hope to uncover new treatment options that could improve corneal sensitivity and nerve function in affected individuals.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with diabetes who are experiencing eye-related complications, particularly those with diabetic keratopathy.
Not a fit: Patients without diabetes or those who do not have any ocular complications related to diabetes may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that prevent or treat vision loss in diabetic patients.
How similar studies have performed: Previous studies have shown promising results with similar approaches, particularly regarding the effects of PPARα agonists on diabetic retinopathy.
Where this research is happening
Fort Worth, United States
- University of North Texas Hlth Sci Ctr — Fort Worth, United States (Active)
Researchers
- Principal investigator: Karamichos, Dimitrios — University of North Texas Hlth Sci Ctr
- Study coordinator: Karamichos, Dimitrios
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.